(Q39586865)

13 September 2017

Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway (English)

1 reference

13 September 2017

11

1 reference

13 September 2017

10

Elisabeth Ralfkiaer

1 reference

13 September 2017

2

Ulrik Ralfkiaer

1 reference

13 September 2017

1

Thorbjørn Krejsgaard

1 reference

13 September 2017

7

Carsten Geisler

0 references

Sally Dabelsteen

object named as

Sally Dabelsteen

series ordinal

8

0 references

Charlotte Menné Bonefeld

object named as

Charlotte M Bonefeld

series ordinal

6

0 references

Mariusz A Wasik

series ordinal

9

object named as

Mariusz A Wasik

1 reference

13 September 2017

5

Katharina L Kopp

1 reference

13 September 2017

3

Erik Clasen-Linde

1 reference

13 September 2017

4

Karsten W Eriksen

1 reference

13 September 2017

Niels Odum

12

1 reference

PubMed ID

21346774

13 September 2017

language of work or name

English

0 references

publication date

24 February 2011

1 reference

Journal of Investigative Dermatology

13 September 2017

1 reference

13 September 2017

131

1 reference

13 September 2017

6

1 reference

13 September 2017

1331-1338

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2011.27

13 September 2017

0 references

cites work

Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Increased CCR4 expression in cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Structure and signalling in the IL-17 receptor family

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

The pathogenesis of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Th17 cells: positive or negative role in tumor?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

A continuous T-cell line from a patient with Sézary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Immunopathogenesis and therapy of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2011.27

1 reference

7 January 2021

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Increased angiogenesis in cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Protumor vs antitumor functions of IL-17.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Therapeutic targeting of Janus kinases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

IL-17 family cytokines and the expanding diversity of effector T cell lineages

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

WHO-EORTC classification for cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Recent patents in the discovery of small molecule inhibitors of JAK3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Targeting STAT3 in cancer: how successful are we?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

T(H)17 cells in tumour immunity and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.27

7 January 2021

Identifiers

DOI

10.1038/JID.2011.27

1 reference

13 September 2017

1 reference

PubMed ID

21346774